MEHLMAN CONSULTING, INC. for ABBOTT LABORATORIES
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health care reform: S. 1796, America's Healthy Future Act of 2009; H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act. H.R. 4872, The Health Care and Education Reconciliation Act of 2010 Food & Drug Administration reforms, prescription drug importation, drug pricing, follow-on biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| JAMIE BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
Medicare/Medicaid MMM
S. 1796, America's Healthy Future Act of 2009; H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act. H.R. 4872, The Health Care and Education Reconciliation Act of 2010 Medicare coverage and reimbursement for end-stage renal disease. Medicare prescription drug coverage.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| JAMIE BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
Pharmacy PHA
S. 1796, America's Healthy Future Act of 2009; H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act. H.R. 4872, The Health Care and Education Reconciliation Act of 2010. FDA reforms; Medicare coverage and reimbursement. Follow on Biologics: H.R.1548, Pathway for Biosimilars Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| JAMIE BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
Taxation/Internal Revenue Code TAX
Deferral, repatriation and other foreign tax issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| JAMIE BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.